Floridienne S.A.

Earnings Release • Nov 28, 2025

Floridienne Group - Press release – Regulated information - 28 November 2025 5.40 pm Transmitted on 28 November 2025 5.40 pm

INTERIM STATEMENT

Financial statements as at 30 September 2025

At the end of September 2025, the Floridienne Group reported trends generally in line with the outlook set out in the half-yearly report, driven by the outstanding performance of BIOTROP, the gradual improvement in BioFirst's historical activities and the positive results posted by the Food Division, despite ongoing pressure on some of the ingredients used.

In the Life Sciences Division, BioFirst continues to develop on the two markets it covers: greenhouse crops (Biobest) and open-field crops (BIOTROP). BIOTROP, the leading Brazilian company in the field of biological solutions for agriculture and one of the biggest in the world, posted exceptional results in the third quarter, recording growth in sales and profitability, in local currency, in excess of 30% over the first nine months of the financial year. This performance confirms the structuring nature of this acquisition for the Group.

BioFirst's historical activities in the greenhouse crops sector posted better results in the third quarter, following a first half year that fell below expectations in a context marked by increased competition in North America. Profitability is gradually recovering thanks to a combination of commercial measures, cost optimisation and demand taking a better direction.

Natix, which brings together our R&D, production and distribution activities for natural bioactives (enzymes, essential oils, snail slime), recorded a higher turnover and improved profitability, driven by the sustained demand among its customers for high added value applications in nutrition, pharmaceuticals and cosmetics. Moreover, on 9 September 2025, Natix acquired a majority holding in the Italian animal enzyme producer Terhormon S.p.A., bringing the Group's total stake to 90.75%. This transaction is fully in line with Floridienne's strategy aimed at strengthening its positions in high-potential niche markets and securing its supply of natural enzymes.

At the end of September, the Food Division posted sales growth, underpinned by the success of the cold sauces ranges both domestically and for export, where the Division continues to develop on new markets. In a context marked by the rise in the price of certain ingredients, margins shrank slightly but the teams are actively continuing their cost management and industrial optimisation actions with a view to maintaining profitability. At the same time, substantial investments have been started to significantly increase the cold sauce production capacities as of 2026 so as to meet the strong demand seen on all markets. The Division continues to focus on the development of its specialities markets and on its operational efficiency.

In the Chemical Division, SNAM continues to develop in the new generation battery recycling sector. Although purified metals prices remain unfavourable and continue to weigh on profitability, the gradual start-up of additional processing capacities is expected to result in an increase in the volumes processed and improve industrial efficiency. Kimflor, our Turkish subsidiary specialising in PVC stabilisers, is showing resilience in a macroeconomic context that continues to be volatile and remains well placed on its markets.

Despite a demanding external environment, the Floridienne Group is facing the future with confidence. BioFirst's unique position in biological control, BIOTROP's strong growth and the robustness of our other activities are sustainable growth levers that bolster the Group's capacity to continue its growth in the medium term. Moreover, the expected developments in European law, aimed at speeding up placing new biocontrol solutions on the market in response to farmers' needs, should also support BIOTROP's international development.

Floridienne Group - Press release – Regulated information - 28 November 2025 5.40 pm Transmitted on 28 November 2025 5.40 pm

Financial calendar

Annual results 2025 31 March 2026 First interim statement 29 May 2026 Ordinary General Meeting 2 June 2026

****************

Contacts: Marc Blanpain, Chairman, and Gaëtan Waucquez, CEO

FLORIDIENNE is a Belgian industrial group listed on the Euronext Brussels stock market that ranks among the European or world leaders in market niches or niche markets. Its activities focus on three sectors: Gourmet Food, Life Sciences and Chemicals.